Cycloserine- and Fluoroquinolone-Induced Seizure in Multidrug-Resistance Tuberculosis (MDR-TB) Patient: A Case Report

Bibliographic Details
Title: Cycloserine- and Fluoroquinolone-Induced Seizure in Multidrug-Resistance Tuberculosis (MDR-TB) Patient: A Case Report
Authors: Dewi Behtri Yanifitri, Yunita Arliny, Wilia Aprilisa Utami, Wira Winardi
Source: Jurnal Respirasi, Vol 10, Iss 1, Pp 61-68 (2024)
Publisher Information: Universitas Airlangga, 2024.
Publication Year: 2024
Collection: LCC:Medicine
Subject Terms: cycloserine, fluoroquinolones, levofloxacin, tuberculosis, seizures, Medicine
More Details: Introduction: Multidrug-resistant tuberculosis (MDR-TB) is a type of tuberculosis (TB) that is resistant to at least two of the most effective first-line anti-TB drugs, isoniazid (H) and rifampicin (R). Cycloserine (Cs) and levofloxacin (Lfx) are second-line anti-TB drugs used in MDR-TB therapy. Even though they are considered to have high effectiveness, both drugs have the potential to cause side effects. One important side effect is neurotoxicity. Seizures have been reported as a common complication of some drugs. Case: A 39-year-old man was diagnosed with MDR-TB and was treated with individual regimens consisting of Lfx, bedaquiline (Bdq), linezolid (Lzd), clofazimine (Cfz), and Cs. After consuming anti-TB drugs for 27 days, the patient had seizures several times. The patient experienced full-body seizures and loss of consciousness during the seizures. Cs and Lfx were discontinued and replaced by other regimens. Serial electroencephalogram (EEG) showed normal results. After Cs and Lfx were discontinued, the patient never had another seizure. Conclusion: Management of MDR-TB is sometimes complicated because of severe drug side effects. Patients taking Cs and fluoroquinolones (FQs) should be advised to report any sign of seizure or changes in mental status to their healthcare provider.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2407-0831
2621-8372
Relation: https://e-journal.unair.ac.id/JR/article/view/43631; https://doaj.org/toc/2407-0831; https://doaj.org/toc/2621-8372
DOI: 10.20473/jr.v10-I.1.2024.61-68
Access URL: https://doaj.org/article/55313ab9730b494ba77d19c95061671f
Accession Number: edsdoj.55313ab9730b494ba77d19c95061671f
Database: Directory of Open Access Journals
More Details
ISSN:24070831
26218372
DOI:10.20473/jr.v10-I.1.2024.61-68
Published in:Jurnal Respirasi
Language:English